Tartaric Acid
Medchemexpress LLC HY-N2522 5mg Medchemexpress, Carboxyatractyloside (dipotassium) CAS:33286-30-5 Purity:>98%
Medchemexpress, HY-N2522 5mg Carboxyatractyloside (dipotassium) CAS:33286-30-5 Carboxyatractyloside dipotassium is a toxic natural product, acts as an inhibitor of ADP/ATP carrier, inhibits mitochondrial ADP/ATP transport. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.
Apexbio Technology LLC ENMD-2076 934353-76-1 5mg
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
Apexbio Technology LLC ENMD-2076 934353-76-1 10mM (in 1mL DMSO)
ENMD-2076 (CAS 934353-76-1) is a selective inhibitor of Aurora A kinase (IC50 14 nM) and FLT3 (IC50 1 86 nM) with additional inhibitory activity against multiple tyrosine kinases implicated in angiogenesis and cell proliferation including RET FLT4/VEGFR3 SRC CSF1R NTRK1 FGFR1/2 VEGFR2/KDR LCK and PDGFR (IC50 1 86 120 nM) ENMD-2076 disrupts cell cycle progression by arresting cells in the G2/M phase through inhibition of Aurora kinases suppresses the PI3K/AKT signaling pathway and demonstrates cytotoxic effects in hematologic malignancy and solid tumor cell lines (in vitro IC50 25 700 nM) In vivo it reduces tumor growth and angiogenesis in xenograft models supporting its use in cancer research and antiangiogenic studies
Chem-Impex International, Inc. D(-)-Tartaric acid | 147-71-7 | MFCD00004238 | 100G
D(-)-Tartaric acid, 147-71-7, MFCD00004238, 100G
Selleck Chemical LLC Tartaric acid S2997-100mg
Tartaric acid (2 3-Dihydroxysuccinic acid) is a white crystalline organic acid isolated from many plants particularly tamarinds and grapes and is used as an antioxidant and an additive agent to give a sour taste
Medchemexpress LLC DL-Tartaric acid | 133-37-9 | 98.0% | 150.09 | C4H6O6 | 500g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Sigma Aldrich Fine Chemicals Biosciences DL-Tartaric acid | 133-37-9 | MFCD00071626
DL-Tartaric acid | Purity: 99% | MW: 150.09 | 133-37-9 | MFCD00071626
Medchemexpress LLC Fosphenytoin disodium | 92134-98-0 | MFCD20527322 | >98.0% | 406.24 g/mol | C16H13N2Na2O6P | 10 MG
Fosphenytoin disodium is the water-soluble disodium salt prodrug of phenytoin supplied for research use only. It functions as an anticonvulsant by reducing repetitive neuronal firing through blockade of voltage-gated sodium channels and is used as a reference compound in pharmacology and analytical studies.
- water-soluble prodrug of phenytoin suitable for biochemical and pharmacological assays.
- high purity (greater than 98%) for reliable experimental results.
- molecular formula C16H13N2Na2O6P and molecular weight approximately 406.24 g/mol.
- provided as a small research pack for analytical standards and in vitro testing.
- intended for research use only; not for human or veterinary use.
Medchemexpress LLC DL-Tartaric acid | 133-37-9 | MFCD00071626 | 98.0% | 150.09 g/mol | C4H6O6 | 250g
DL-Tartaric acid is an orally active and non-racemic mixture of L- and D-tartaric acid with antioxidant activity 14C-labeled DL-Tartaric acid is nephrotoxic[1][2][3]
Selleck Chemical LLC ENMD-2076 L-()-Tartaric acid S2018-5mg
ENMD-2076 L-( )-Tartaric acid is the tartaric acid of ENMD-2076 selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1 86 nM 25-fold more selective for Aurora A than Aurora B and less potent to VEGFR2/KDR and VEGFR3 FGFR1 and FGFR2 and PDGFR Phase 2